Monday, November 21, 2016

BRIEF-GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older

* GSK receives FDA approval for expanded indication for

flulaval quadrivalent (influenza vaccine) for infants 6 months

and older

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)